blue arrowHealth blue arrowFunding blue arrowNews blue arrowResearch at NEI blue arrowEducation blue arrowJobs blue arrowAbout NEI blue arrowResources
Home » Age-Related Eye Disease Study--Results
NEI and AREDS logos

Age-Related Eye Disease Study--Results

The Age-Related Eye Disease Study (AREDS) is a major clinical trial sponsored by the National Eye Institute, one of the Federal government's National Institutes of Health.

The AREDS was designed to:

Results from the AREDS showed that high levels of antioxidants and zinc significantly reduce the risk of advanced age-related macular degeneration (AMD) and its associated vision loss. These same nutrients had no significant effect on the development or progression of cataract.

The NEI has launched the Age-Related Eye Disease Study 2 (AREDS2). Nearly 100 clinical centers are now seeking 4,000 study participants ages 50 - 85 who have AMD. Learn more about AREDS2.


Summary of AREDS Results

Frequently Asked Questions

Press Release-AREDS Results, October 12, 2001

Backgrounder

Participating Clinical Centers

Archives of Ophthalmology-October 2001

AREDS Description from the NEI's Clinical Studies Database
(includes journal citations)

Age-Related Macular Degeneration-Information for Patients

Cataract-Information for Patients

This page was last modified in May 2007